These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3621151)

  • 41. Membrane transport of mitoxantrone by L1210 leukemia cells.
    Burns CP; Haugstad BN; North JA
    Biochem Pharmacol; 1987 Mar; 36(6):857-60. PubMed ID: 3566786
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased gene specific repair of cisplatin induced interstrand crosslinks in cisplatin resistant cell lines, and studies on carrier ligand specificity.
    Petersen LN; Mamenta EL; Stevnsner T; Chaney SG; Bohr VA
    Carcinogenesis; 1996 Dec; 17(12):2597-602. PubMed ID: 9006094
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Determinants of cisplatin sensitivity in non-malignant non-drug-selected human T cell lines.
    Dabholkar M; Parker R; Reed E
    Mutat Res; 1992 Jun; 274(1):45-56. PubMed ID: 1375331
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Highly efficient uptake into cisplatin-resistant cells and the isomerization upon coordinative DNA binding of anticancer tetrazolato-bridged dinuclear platinum(II) complexes.
    Uemura M; Hoshiyama M; Furukawa A; Sato T; Higuchi Y; Komeda S
    Metallomics; 2015 Nov; 7(11):1488-96. PubMed ID: 26393664
    [TBL] [Abstract][Full Text] [Related]  

  • 45. P-glycoprotein depresses cisplatin sensitivity in L1210 cells by inhibiting cisplatin-induced caspase-3 activation.
    Gibalová L; Sereš M; Rusnák A; Ditte P; Labudová M; Uhrík B; Pastorek J; Sedlák J; Breier A; Sulová Z
    Toxicol In Vitro; 2012 Apr; 26(3):435-44. PubMed ID: 22269388
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Flux of teniposide (VM-26) across the plasma membrane of teniposide-resistant sublines of L1210 cells.
    Lee T; Roberts D
    Cancer Res; 1984 Jul; 44(7):2986-90. PubMed ID: 6722822
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Possible coexistence of two independent mechanisms contributing to anthracycline resistance in leukaemia P388 cells.
    Soto F; Planells-Cases R; Canaves JM; Ferrer-Montiel AV; Aleu J; Gamarro F; Castanys S; Gonzalez-Ros JM; Ferragut JA
    Eur J Cancer; 1993; 29A(15):2144-50. PubMed ID: 7905276
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Some biochemical characteristics of L1210 cell lines resistant to 6-mercaptopurine and 6-thioguanine and with increased sensitivity to methotrexate.
    Strobel-Stevens JD; El Dareer SM; Trader MW; Hill DL
    Biochem Pharmacol; 1982 Oct; 31(19):3133-7. PubMed ID: 6890814
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Involvement of mitochondrial dynamics in the antineoplastic activity of cisplatin in murine leukemia L1210 cells.
    Han XJ; Shi SL; Wei YF; Jiang LP; Guo MY; Wu HL; Wan YY
    Oncol Rep; 2017 Aug; 38(2):985-992. PubMed ID: 28677814
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tetravalent platinum complexes with ammine/amine carrier ligand configuration: circumvention of platinum resistance in vivo.
    Siddik ZH; Thai G; Yoshida M; Zhang YP; Khokhar AR
    Anticancer Drug Des; 1994 Dec; 9(6):495-509. PubMed ID: 7880375
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Uptake of adriamycin and daunomycin in L1210 and human leukemia cells: a comparative study.
    Chervinsky DS; Wang JJ
    J Med; 1976; 7(1):63-79. PubMed ID: 1064679
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Changes in calcium channel activity in membranes from cis-diammine-dichloroplatinum(II)-resistant and -sensitive L1210 cells.
    Vassilev PM; Kanazirska MP; Charamella LJ; Dimitrov NV; Tien HT
    Cancer Res; 1987 Jan; 47(2):519-22. PubMed ID: 2431772
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Response of drug-sensitive and -resistant L1210 leukemias to high-dose chemotherapy.
    Griswold DP; Trader MW; Frei E; Peters WP; Wolpert MK; Laster WR
    Cancer Res; 1987 May; 47(9):2323-7. PubMed ID: 3567926
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Uptake and intracellular distribution of 4,4'-diacetyldiphenylurea-bis-(Guanylhydrazone) in sensitive and resistant leukemia L1210 cells.
    Dave C; Mihich E
    Biochem Pharmacol; 1972 Oct; 21(20):2681-95. PubMed ID: 4675029
    [No Abstract]   [Full Text] [Related]  

  • 55. Mitomycin C resistant L1210 leukemia cells: association with pleiotropic drug resistance.
    Dorr RT; Liddil JD; Trent JM; Dalton WS
    Biochem Pharmacol; 1987 Oct; 36(19):3115-20. PubMed ID: 3117061
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Oncogene expression in adriamycin and platinum resistant cell lines].
    Liu YB
    Zhonghua Yi Xue Za Zhi; 1993 Sep; 73(9):552-4, 576. PubMed ID: 7906188
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cell surface properties of L1210 leukaemia cells.
    Csuka O; Sugár J
    Acta Morphol Acad Sci Hung; 1976; 24(4):297-305. PubMed ID: 1032277
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anticancer activity in murine and human tumor cell lines of bis(platinum) complexes incorporating straight-chain aliphatic diamine linker groups.
    Kraker AJ; Hoeschele JD; Elliott WL; Showalter HD; Sercel AD; Farrell NP
    J Med Chem; 1992 Nov; 35(24):4526-32. PubMed ID: 1335074
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Cisplatin resistance in a murine leukemia cell line associated with defect of apoptosis].
    Segal-Bendirdjian E; Jacquemin-Sablon A
    Bull Cancer; 1996 May; 83(5):371-8. PubMed ID: 8680089
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The mechanism of the difference in cellular uptake of platinum derivatives in non-small cell lung cancer cell line (PC-14) and its cisplatin-resistant subline (PC-14/CDDP).
    Ohmori T; Morikage T; Sugimoto Y; Fujiwara Y; Kasahara K; Nishio K; Ohta S; Sasaki Y; Takahashi T; Saijo N
    Jpn J Cancer Res; 1993 Jan; 84(1):83-92. PubMed ID: 8383649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.